These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29360470)

  • 1. CDK5RAP2 gene and tau pathophysiology in late-onset sporadic Alzheimer's disease.
    Miron J; Picard C; Nilsson N; Frappier J; Dea D; Théroux L; ; ; Poirier J
    Alzheimers Dement; 2018 Jun; 14(6):787-796. PubMed ID: 29360470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic study of multimodal imaging Alzheimer's disease progression score implicates novel loci.
    Scelsi MA; Khan RR; Lorenzi M; Christopher L; Greicius MD; Schott JM; Ourselin S; Altmann A
    Brain; 2018 Jul; 141(7):2167-2180. PubMed ID: 29860282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease.
    Potkin SG; Guffanti G; Lakatos A; Turner JA; Kruggel F; Fallon JH; Saykin AJ; Orro A; Lupoli S; Salvi E; Weiner M; Macciardi F;
    PLoS One; 2009 Aug; 4(8):e6501. PubMed ID: 19668339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive Decline in Alzheimer's Disease: Limited Clinical Utility for GWAS or Polygenic Risk Scores in a Clinical Trial Setting.
    Euesden J; Gowrisankar S; Qu AX; Jean PS; Hughes AR; Pulford DJ
    Genes (Basel); 2020 May; 11(5):. PubMed ID: 32370229
    [No Abstract]   [Full Text] [Related]  

  • 5. Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels.
    Maxwell TJ; Corcoran C; Del-Aguila JL; Budde JP; Deming Y; Cruchaga C; Goate AM; Kauwe JSK;
    Alzheimers Res Ther; 2018 Aug; 10(1):86. PubMed ID: 30153862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive resilience to Alzheimer's disease characterized by cell-type abundance.
    O'Neill N; Stein TD; Olayinka OA; Empawi JA; Hu J; Tong T; Zhang X; Farrer LA
    Alzheimers Dement; 2024 Oct; 20(10):6910-6921. PubMed ID: 39262221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linking Genetics of Brain Changes to Alzheimer's Disease: Sparse Whole Genome Association Scan of Regional MRI Volumes in the ADNI and AddNeuroMed Cohorts.
    Khondoker M; Newhouse S; Westman E; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Lovestone S; Dobson R; Simmons A; ;
    J Alzheimers Dis; 2015; 45(3):851-64. PubMed ID: 25649652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of genomic organisation, sequence variants and analysis of the role of the human dishevelled 1 gene in late onset Alzheimer's disease.
    Russ C; Lovestone S; Powell JF
    Mol Psychiatry; 2002; 7(1):104-9. PubMed ID: 11803455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.
    Herold C; Hooli BV; Mullin K; Liu T; Roehr JT; Mattheisen M; Parrado AR; Bertram L; Lange C; Tanzi RE
    Mol Psychiatry; 2016 Nov; 21(11):1608-1612. PubMed ID: 26830138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease.
    Furney SJ; Simmons A; Breen G; Pedroso I; Lunnon K; Proitsi P; Hodges A; Powell J; Wahlund LO; Kloszewska I; Mecocci P; Soininen H; Tsolaki M; Vellas B; Spenger C; Lathrop M; Shen L; Kim S; Saykin AJ; Weiner MW; Lovestone S; ;
    Mol Psychiatry; 2011 Nov; 16(11):1130-8. PubMed ID: 21116278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel quantitative traits-associated susceptibility loci for APOE ε 4 non-carriers of Alzheimer's disease.
    Jiang S; Yang W; Qiu Y; Chen HZ;
    Curr Alzheimer Res; 2015; 12(3):218-27. PubMed ID: 25731621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide association study identifies two loci influencing plasma neurofilament light levels.
    Li JQ; Yuan XZ; Li HY; Cao XP; Yu JT; Tan L; Chen WA;
    BMC Med Genomics; 2018 May; 11(1):47. PubMed ID: 29747637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease.
    Gabriel AJ; Almeida MR; Ribeiro MH; Carneiro D; Valério D; Pinheiro AC; Pascoal R; Santana I; Baldeiras I
    J Alzheimers Dis; 2018; 61(3):1097-1105. PubMed ID: 29254094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease: analyzing the missing heritability.
    Ridge PG; Mukherjee S; Crane PK; Kauwe JS;
    PLoS One; 2013; 8(11):e79771. PubMed ID: 24244562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective genes and pathways in Alzheimer's disease: moving towards precision interventions.
    Seto M; Weiner RL; Dumitrescu L; Hohman TJ
    Mol Neurodegener; 2021 Apr; 16(1):29. PubMed ID: 33926499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genes associated with the progression of neurofibrillary tangles in Alzheimer's disease.
    Miyashita A; Hatsuta H; Kikuchi M; Nakaya A; Saito Y; Tsukie T; Hara N; Ogishima S; Kitamura N; Akazawa K; Kakita A; Takahashi H; Murayama S; Ihara Y; Ikeuchi T; Kuwano R;
    Transl Psychiatry; 2014 Jun; 4(6):e396. PubMed ID: 26126179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
    Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A
    Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data integration for functional annotation of regulatory single nucleotide polymorphisms associated with Alzheimer's disease susceptibility.
    Amber S; Zahid S
    Gene; 2018 Sep; 672():115-125. PubMed ID: 29883757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.